Showing 1 - 2 results of 2 for search 'Andrei Cianga', query time: 0.01s Refine Results
  1. 1
    The Benefit of Brentuximab Vedotin and Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Single-Center Retrospective Study

    The Benefit of Brentuximab Vedotin and Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Single-Center Retrospective Study by Diana-Marina FORTOES, Elena NICORICI, Cosmin MINCIUNA, Andrei CIANGA, Ramona TIMOFTE, Amalia TITIEANU, Elena DOLACHI-PELIN, Ion ANTOHE, Angela DASCALESCU, Catalin DANAILA

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Challenges in the preclinical design and assessment of CAR-T cells

    Challenges in the preclinical design and assessment of CAR-T cells by Radu Tomai, Radu Tomai, Javier De Las Rivas, Bogdan Fetica, Bogdan Fetica, Rui Bergantim, Rui Bergantim, Rui Bergantim, Rui Bergantim, Brankica Filipic, Zarko Gagic, Katarina Nikolic, Diana Gulei, Diana Gulei, David Kegyes, David Kegyes, Madalina Nistor, Madalina Nistor, Ximena Maria Muresan, Ximena Maria Muresan, Diana Cenariu, Diana Cenariu, Richard Feder, Richard Feder, Mariana Pavel-Tanasa, Andrei Cianga, Adrian Bogdan Tigu, Adrian Bogdan Tigu, Raluca Munteanu, Raluca Munteanu, Alina Tanase, Hermann Einsele, Hermann Einsele, Hermann Einsele, Ciprian Tomuleasa, Ciprian Tomuleasa

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: